Results show potential of J&J’s TAR-210 to transform treatment of bladder cancer with FGFR alterations Read more
Sheffield University gets £3.1 mn for trials to better bladder, prostate cancer diagnosis, treatment Read more
Roche says Tecentriq prevents disease worsening or death in patients with advanced bladder cancer Read more